Group 1 - The stock price of Haiwang Biological (000078) closed at 2.42 yuan on June 27, 2025, an increase of 2.11% from the previous week, with a market cap of 6.367 billion yuan [1] - Haiwang Biological's market capitalization ranks 15th out of 31 in the pharmaceutical commercial sector and 2441st out of 5151 in the A-share market [1] - The company provided guarantees for several subsidiaries, including a total of 800 million yuan for Henan Haiwang Pharmaceutical Group and 300 million yuan for Henan Dongsen Pharmaceutical [1] Group 2 - The total amount of guarantees provided by the company for its subsidiaries is approximately 1.7 billion yuan [3] - The full subsidiary Shandong Haiwang Galaxy Pharmaceutical signed a construction contract for the first phase of the Haiwang Modern Smart Pharmaceutical Logistics Park project, with a total investment of 134.5 million yuan [2][3] - The construction project has a total area of 63,525.77 square meters and a duration of 660 days [2]